Skip to content

XTI Aerospace, Inc. XTIA Proceeds From Issuance Of Convertible Preferred Stock

Proceeds From Issuance Of Convertible Preferred Stock at other companies

Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$26.55M
XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$5.69M
HTF
Heartflow, Inc. Common StockHTFL
$42.24M
KKR & Co. logo
KKR & Co.KKR
$0-100%
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
$0
OS Therapies logo
OS TherapiesOSTX
$1.05M-30.4%

Other financials

Income statement

See full
Revenue$27.7M+5,622%
Gross profit$5.1M+1,436%
Operating income-$10.4M-26.7%
Net income-$35.3M-174%
EPS (diluted)-$1.00+73.7%

Balance sheet

See full
Cash & equivalents$15.2M+89.6%
Total debt$22.8M+14,541%
Total equity-$26.6M-291%
Total assets$78.3M+189%

Cash flow

See full
Operating cash flow-$10.5M+31.4%
CapEx$131.0K+191%
Free cash flow-$10.6M+30.8%

Valuation

See full
Market cap$69.64M+166%
Enterprise value$77.3M+1,088%
P/S1.4×-7.2×

Profitability

See full
Gross margin19.6%-40.5pp
Operating margin-86.1%-40.7pp
Net margin-183.4%-84.9pp
FCF margin-64.6%-31.3pp

Returns & leverage

See full
Return on equity-565.7%
Debt / equity1.1×+0.6×
Current ratio0.6×-0.4×

Where this comes from

Reported directly by XTI Aerospace, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock.

The official record: XTI Aerospace, Inc.’s 10-K, filed April 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about XTI Aerospace, Inc.'s proceeds from issuance of convertible preferred stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XTI Aerospace, Inc.'s proceeds from issuance of convertible preferred stock?
XTI Aerospace, Inc. (XTIA) reported proceeds from issuance of convertible preferred stock of $5.69M in Q4 2025.
What does proceeds from issuance of convertible preferred stock mean?
Cash inflows resulting from the issuance of preferred shares that carry the option to be converted into common stock. This highlights the company's use of hybrid financing instruments to balance capital needs with potential future equity dilution.